IP Library Granted Patent US 9,024,055
Granted Patent B2
US 9,024,055 · App. 14/346,689 · Granted May 5, 2015

Acetaminophen conjugates, compositions and methods of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,024,055
App. No.
14/346,689
Granted
May 5, 2015
Kind
B2
Abstract

Acetaminophen conjugates are provided, which have an acetaminophen moiety covalently linked to a second moiety. The conjugates provided may have one or more advantageous properties, including increased water solubility as compared to acetaminophen, reduced toxicity profile as compared to acetaminophen and an altered pharmacokinetic profile. Formulations comprising the conjugates are also provided, as are methods of using the conjugates and kits comprising the conjugates.

Claims (11)

1. A compound of the formula (I):

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein the compound is a salt of the formula (Ia):

3. A compound of the formula (II):

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 3 wherein the compound is a salt of the formula (IIa):

5. A formulation comprising a compound of claim 1 or 3 and a pharmaceutically acceptable carrier.

6. The formulation of claim 5 , wherein the pharmaceutically acceptable carrier comprises saline.

7. A method of treating a disease or condition selected from the group consisting of pain, fever, inflammation, ischemic injury, and neuronal injury, comprising administering to an individual in need thereof an effective amount of a compound according to claim 1 or 3 .

8. The method of claim 7 , wherein the compound is administered parenterally.

9. A kit for the treatment or prevention of a disease or condition selected from the group consisting of pain, fever, inflammation, ischemic injury, and neuronal injury, comprising a compound of claim 1 or 3 , or a pharmaceutically acceptable salt thereof and instructions for use.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
SECURITY INTEREST Recorded Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2014
From: BLEY, KEITH R.; JANDELEIT, BERND
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 034438/0487 →